The work presented here is an expansion of the breast cancer data presented by Straume et al, and focuses on two new aspects: (1) the inter-relationship between GMP, p53 overexpression and BRCA1/2 status and (2) the effect of GMP on prognosis in the presence or absence of adjuvant chemotherapy. Here, TP53 is linked to breast cancer.